Next report date
Report period
Q2 2024
EPS estimate
1.67CHF
Revenue estimate
11.20 BCHF
6.574CHF
13.34 BCHF
40.83 BCHF
1.75 B
About NOVARTIS N
Sector
CEO
Vasant Narasimhan
Headquarters
Basel
Website
Employees (FY)
76.06 K
Founded
1996
ISIN
CH0012005267
FIGI
BBG008B4YSV8
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where NOT is featured.
Frequently Asked Questions
The current price of NOT is 89.954 CHF — it has decreased by 0.11% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange NOVARTIS AG stocks are traded under the ticker NOT.
NOVARTIS AG is going to release the next earnings report on Jul 18, 2024. Keep track of upcoming events with our Earnings Calendar.
NOT stock is 0.11% volatile and has beta coefficient of 0.66. Check out the list of the most volatile stocks — is NOVARTIS AG there?
NOT earnings for the last quarter are 1.29 CHF per share, whereas the estimation was 1.39 CHF resulting in a −7.31% surprise. The estimated earnings for the next quarter are 1.51 CHF per share. See more details about NOVARTIS AG earnings.
NOVARTIS AG revenue for the last quarter amounts to 9.62 B CHF despite the estimated figure of 10.01 B CHF. In the next quarter revenue is expected to reach 10.32 B CHF.
Yes, you can track NOVARTIS AG financials in yearly and quarterly reports right on TradingView.
NOT stock has risen by 7.01% compared to the previous week, the month change is a 4.23% rise, over the last year NOVARTIS AG has showed a 2.37% decrease.
NOT net income for the last quarter is 2.35 B CHF, while the quarter before that showed 7.52 B CHF of net income which accounts for −68.76% change. Track more NOVARTIS AG financial stats to get the full picture.
Today NOVARTIS AG has the market capitalization of 176.08 B, it has increased by 2.78% over the last week.
Yes, NOT dividends are paid annually. The last dividend per share was 3.30 CHF. As of today, Dividend Yield (TTM)% is 3.67%. Tracking NOVARTIS AG dividends might help you take more informed decisions.
NOVARTIS AG dividend yield was 3.89% in 2023, and payout ratio reached 51.36%. The year before the numbers were 3.83% and 105.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, NOT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVARTIS AG stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 76.06 K employees. See our rating of the largest employees — is NOVARTIS AG on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVARTIS AG technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVARTIS AG stock shows the buy signal. See more of NOVARTIS AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NOVARTIS AG future price: according to them, NOT price has a max estimate of 119.71 CHF and a min estimate of 74.41 CHF. Read a more detailed NOVARTIS AG forecast: see what analysts think of NOVARTIS AG and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVARTIS AG EBITDA is 18.76 B CHF, and current EBITDA margin is 44.33%. See more stats in NOVARTIS AG financial statements.